Global Inferior Vena Cava Filters Market

Inferior Vena Cava Filters Market Size, Share, Growth Analysis, By Product Type(Retrievable Filters and Permanent Filters), By Placement(Permanent Placement, Temporary Placement), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2557 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 60 | Figures: 70

Inferior Vena Cava Filters Market News

  • February 2023: Cook Medical received FDA approval for its Celect Vena Cava Filter, a new generation of retrievable IVC filter. The Celect Vena Cava Filter is designed to be more flexible and easier to insert than previous generations of filters, and it also has a retrieval rate of over 90%.
  • January 2023: Bard Access Systems announced that it has received FDA approval for its Eclipse IVC Filter, a new generation of permanent IVC filter. The Eclipse IVC Filter is designed to be more durable and less likely to migrate than previous generations of filters.
  • December 2022: Boston Scientific acquired Veniti, a company that develops IVC filters that are designed to be more retrievable than traditional filters. The acquisition is expected to strengthen Boston Scientific's position in the IVC filter market.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Inferior Vena Cava Filters Market size was valued at USD 783.6 million in 2022 and is poised to grow from USD 849.66 million in 2023 to USD 1623.45 million by 2031, growing at a CAGR of 8.43% in the forecast period (2024-2031).

The competitive landscape of the inferior vena cava filters market is characterized by the presence of key industry players and emerging entrants focusing on innovation, product development, and strategic collaborations. Leading companies such as Boston Scientific Corporation, Cook Medical, Cordis Corporation (a Cardinal Health company), B. Braun Melsungen AG, and C.R. Bard, Inc. (acquired by BD) dominate the market with their established product portfolios and presence. These players continually invest in research and development to enhance their offerings and address the evolving needs of healthcare professionals and patients. 'Boston Scientific Corporation', 'Cook Medical', 'Cordis Corporation (a Cardinal Health company)', 'B. Braun Melsungen AG', 'C.R. Bard, Inc. (acquired by BD)', 'Johnson & Johnson', 'Medtronic plc', 'Abbott Laboratories', 'Terumo Corporation', 'Becton, Dickinson and Company (BD)', 'Merit Medical Systems, Inc.', 'Argon Medical Devices, Inc.', 'Teleflex Incorporated', 'Cardinal Health, Inc.', 'ALN Implants Chirurgicaux'

The rising prevalence of VTE cases, including deep vein thrombosis (DVT) and pulmonary embolism (PE), drives the demand for inferior vena cava filters as preventive measures.

Retrievable Filters Dominance: The market is witnessing a shift towards retrievable filters due to their flexibility and potential for removal, aligning with patient-centric care and minimizing long-term risks.

The largest region in the inferior vena cava filters market is North America. The region's dominance can be attributed to its well-established healthcare infrastructure, high awareness about venous thromboembolism (VTE) risks, and a significant prevalence of conditions warranting the use of inferior vena cava filters. The United States, in particular, contributes significantly to the market due to its advanced medical facilities and widespread adoption of medical technologies.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Inferior Vena Cava Filters Market

Report ID: SQMIG35A2557

$5,300
BUY NOW GET FREE SAMPLE